Biogen's managed trade regains momentum
Biogen stock rises 3.3% as the technical picture strengthens across the board
Our view last week
Biogen closes the week up 0.9%, rebounding 4% off the daily 20-day moving average tested in the 201 area. The weekly picture stays constructive but not clean: mixed rejection candles and an indecisive phase show up, while the weekly RSI climbs to 61.5 and money flow stays positive. The trade, under management for 14 weeks, sits at +8.47% since entry, with the stop now well above breakeven.
This week's summary
Biogen stock closes the week up 3.3%, with buyers holding 63% of volume and the weekly RSI climbing to 65.1, its highest in the past four weeks. The MACD has just moved back above its Signal line after three weeks below it, and money flow has stayed positive for 11 weeks, even as its pace slows. Weekly price action stays constructive, with two warnings to watch: contracting volumes and a still-indecisive phase.
IQS Phase
67
in tension
Signal Strength
55
medium
Sizing
STANDARD
Ranking
#80 / 167
US stocks in progress
Trade P&L %
+12.06%
from signal to date, no stop loss
Rank position
ranks 80th among the 167 Longs already running for US stocks in our ranking, with a signal strength of 55 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly +4.33% · monthly +9.53%
BIIB belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content